Table 1 Prevalence of anaemia in patients with CKD
Class CKD | Hb < 13 g/dl(M)* | Hb > 11 g/dl | Hb ≤ 11 g/dl** | Hb ≤ 10 g/dl*** | Hb ≤ 9 g/dl | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|  |  | Hb < 12 g/dl(F) |  |  |  |  |  |  |  |  | |
| Â | Â | N | % | N | % | N | % | N | % | N | % |
eGFR > 90 | F | 11545 | 18.5% | 61287 | 92.8% | 4732 | 7.2% | 1523 | 2.3% | 536 | 0.8% |
| Â | M | 3552 | 6.3% | 54902 | 98.6% | 790 | 1.4% | 340 | 0.6% | 142 | 0.3% |
eGFR 60-89 | F | 16032 | 11.1% | 132285 | 96.0% | 5455 | 4.0% | 1747 | 1.3% | 612 | 0.4% |
| Â | M | 7228 | 6.0% | 106310 | 98.8% | 1281 | 1.2% | 541 | 0.5% | 235 | 0.2% |
Stage 3A | F | 4542 | 14.3% | 28205 | 94.5% | 1654 | 5.5% | 508 | 1.7% | 173 | 0.6% |
| Â | M | 2997 | 20.4% | 12760 | 95.1% | 657 | 4.9% | 254 | 1.9% | 101 | 0.8% |
Stage 3B | F | 2340 | 36.4% | 5065 | 82.6% | 1065 | 17.4% | 329 | 5.4% | 96 | 1.6% |
| Â | M | 1616 | 48.7% | 2654 | 83.5% | 523 | 16.5% | 207 | 6.5% | 86 | 2.7% |
Stage 4 | F | 663 | 59.8% | 680 | 63.6% | 389 | 36.4% | 167 | 15.6% | 35 | 3.3% |
| Â | M | 553 | 71.3% | 516 | 69.2% | 230 | 30.8% | 102 | 13.7% | 38 | 5.1% |
Stage 5 | F | 128 | 61.2% | 108 | 55.1% | 88 | 44.9% | 43 | 21.9% | 16 | 8.2% |
| Â | M | 176 | 81.5% | 123 | 59.4% | 84 | 40.6% | 38 | 18.4% | 18 | 8.7% |
CKD stage 3-5 | F | 7673 | 19.4% | 34058 | 91.4% | 3196 | 8.6% | 1047 | 2.8% | 320 | 0.9% |
| Â | M | 5342 | 28.1% | 16053 | 91.5% | 1494 | 8.5% | 601 | 3.4% | 243 | 1.4% |
Total CKD 3-5 | 13015 | 22.2% | 50111 | 91.4% | 4690 | 8.6% | 1648 | 3.0% | 563 | 1.0% | |